(6S)-CP-470711（Compound 8）作为一种山梨醇脱氢酶（sorbitol dehydrogenase, SDH）抑制剂，对人类及大鼠SDH的抑制活性表现出来，其IC50值分别为19 nM和27 nM。此外，(6S)-CP-470711能有效改善由Streptozotocin引起的大鼠糖尿病症状。

SDH-IN-5是一种强效的琥珀酸脱氢酶抑制剂 (SDHI)。它通过干扰真菌呼吸链复合物 II 的电子传递阻断其能量代谢，对多种农作物致病真菌表现出广谱杀灭活性，常用于植物病理学研究。

HSD17B13-IN-3（化合物2）是一种有效的HSD17B13抑制剂，但不具备细胞实验活性。

T-3764518 is a novel and potent inhibitor of stearoyl coenzyme A desaturase (SCD)(IC50 of 4.7 nM).

MCI-INI-3 是一种选择性竞争性抑制剂，专门抑制人ALDH1A3 (Ki值为 0.55 μM，而对ALDH1A1的 Ki值为 78.2 μM)。MCIINI-3 能够抑制视黄酸的生物合成，并降低 GSC-83 和 GSC-326 胶质母细胞瘤细胞的活力。

Aldi-2 是一种高效特异的醛脱氢酶 (ALDHs) 共价抑制剂，对ALDH1A1、ALDH2和ALDH3A1的IC50分别为2.5 μM、6.4 μM和1.9 μM。Aldi-2 可应用于癌症研究。

ASP3662, also known as SPI-62, is a potent, selective and CNS-penetrable inhibitor of 11β-HSD1. The effects of ASP3662 suggest that selective inhibition of 11β-HSD1 may be an attractive approach for the treatment of neuropathic and dysfunctional pain, as observed in fibromyalgia. ASP3662 inhibited human, mouse and rat 11β-HSD1 but not human 11β-HSD2, in vitro. ASP3662 inhibited in vitro conversion of glucocorticoid from its inactive to active form in extracts of rat brain and spinal cord.

DHODH-IN-21 是口服具有活力的、选择性二氢乳酸脱氢酶 (DHODH) 抑制剂 (IC50: 1.1 nM)。DHODH-IN-21 表现出抗癌作用，能够用于研究急性髓性白血病 (AML)。

DSM705 is a pyrrole-based inhibitor of Dihydroorotate Dehydrogenase (DHODH). It demonstrates high potency in the nanomolar range against Plasmodium DHODH and Plasmodium parasites, while not interfering with mammalian DHODHs. DSM705 shows significant efficacy as an antimalarial compound.